CardioPulmonary Vascular Biology COBRE
The overall objective of the CardioPulmonary Vascular Biology COBRE is to bring together a group of investigators in the fields of pulmonary and cardiovascular diseases in a unique trans-disciplinary approach to improve understanding of the pathogenesis and treatment of vascular pathobiology in lung and heart diseases. The Specific Aims of this proposal are…
Announcements & Kudos
Important Links
CORES RI
Lifespan
Brown University
VA Research
Relevance
Cardiovascular and lung vascular diseases are important causes of morbidity and mortality in the US. A multidisciplinary group of MD, PhD, and MD/PhD investigators will develop a research center focusing on understanding the biology of vascular injury. Improved understanding of mechanisms of blood vessel injury promotes development of new and innovative treatments. This Vascular Biology COBRE will be first of its kind in Rhode Island, a state with a high burden of both heart and lung disease.
The Rhode Island IDeA symposium is a gathering to share best practices and better coordinate the translational research and faculty development programs across the state. Keynote presenter Mark Gillespie, PhD Chair of Pharmacology at the University of South Alabama presented Oxidant-DNA interaction in the life and death of cells: A tale of two genomes. A second combined Keynote presentation was given by Stephen Fiore, PhD, Director, Cognitive Sciences, UCF Department of Philosophy & Kara Hall, PhD, Science of Research and Technology Branch (SRTB), Behavioral Research Program (BRP) NIH. Together they presented Enhancing Collaboration in Cross Disciplinary Science.
Rhode Island Thoracic Society meeting guest speaker Dr. Talmadge King, MD, March 2015
Providence VA Medical Center
Grant Awarded to OSRI will Further CardioPulmonary Research at Local Institutions
/in Front Page News, News /by adminPROVIDENCE, R.I. – The National Institute for General Medical Sciences of the National Institutes of Health has awarded a $10.1 million, 5-year grant to establish the CardioPulmonary Vascular Biology Center of Biomedical Research Excellence (COBRE).